John Aballi

John Aballi

President, Chief Executive Officer, Director and former Interim Chief Financial OfficeratExagen· In proxies 2022–2025

Pay in FY2025+18% from the year before · Exagen stock +48.3% the same year

John Aballi was paid $1.4M in FY2025 (Dec), up 18%. Exagen stock rose 48.3% that year.

Pay$100 in the stock at the end of FY21 → $52
Pay is from the Summary Compensation Table of each Exagen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ExagenPublic company · 4 yr
    • President, Chief Executive Officer, Director and former Interim Chief Financial Officer2022 – Present · 4 yrStock in role -24%
  2. San DiegoPublic company
    • Director? – PresentNo stock prices for these years
  3. PFS Genomics Inc.Public company · Less than 1 yr
    • Director2021 – 2021 · Less than 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?